Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India EP News Bureau Nov 21, 2019 Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India Viveka Roychowdhury Aug 21, 2019 Lara Yumi Tsuji Bezerra, Managing Director, Roche India came to India with close to 24 years of pharma experience, across sales,…
